Brief: Entero Therapeutics Inc Subsidiary Immunogenx Enters Settlement Agreement
14/05/2025 22:17
May 14 (Reuters) - Entero Therapeutics Inc ENTO.O: ENTERO THERAPEUTICS INC - SUBSIDIARY IMMUNOGENX ENTERS SETTLEMENT AGREEMENT - SEC FILING ENTERO THERAPEUTICS INC - GUARANTORS TO PAY $5.5 MILLION TO MATTRESS LIQUIDATORS - SEC FILING Further company coverage: ENTO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on GridAI Technologies
See all newsBrief: Gridai Technologies Corp - Enters $2.54 Million Private Placement Of Shares And Warrants - SEC Filing
Brief: IBN Announces Latest Episode Of The Techmediawire Podcast Featuring Marshall Chapin, CEO Of Grid Ai Corp.
Brief: Entero Therapeutics Terminated Interim CEO And Chairman Richard Joel Paolone Effective Immediately - SEC Filing
Brief: Entero Therapeutics Inc - Now Offering 15.2 Million Shares Of Common Stock
Brief: Entero Therapeutics Inc Subsidiary Immunogenx Enters Settlement Agreement